Evaluation of Different Fractions of Garcinia kola Extracts against Multidrug Resistant Clinical Bacterial and Fungal Isolates

Badger-Emeka, Khalil, and Emeka: Evaluation of Different Fractions of Garcinia kola Extracts against Multidrug Resistant Clinical Bacterial and Fungal Isolates

Authors

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-5-1055_g000.jpg

INTRODUCTION

The use of herbal produce in the treatment of various ailments continue to receive worldwide attention by researchers as traditional medicines derived from plants have become highly important as alternative medicines in the treatment of a huge number of diseases.1-2 These plant derivatives are considered safe and more affordable for majority of the developing world. There are reports of an increase in the use of these plant produce in the developed world3 and more so with the emergence of difficult to treat bacterial infections, attention is again drawn to the use herbal alternatives. One of a long standing in use is the Garcinia kola.

Garcinia kola is commonly referred to in Nigeria as “Bitter kola” due to it characteristic bitter taste. The plant is grown in the humid regions of Western and Central Africa.4-5 The tropical plant Garcinia belongs to the family Clusiaceae with origins said to be Asia, Australia, tropical and Southern Africa.6 The seeds of the plant, bitter kola, are used by some tribes in Nigeria for various ceremonial celebrations such as weddings, child naming ceremonies amongst others. At such celebrations, they are chewed as snacks7 and there is no specific amount that can be chewed at a sitting due to it friendliness to the digestive system.7 Chewing is believed to have a mechanical cleansing effect with the release of antimicrobial agents.8 Also, chewing of the seeds is reported to bring relief to coughs, colds and throat infections while earlier reports by Iwu9 stipulated that the plant derivatives are used in the treatment of liver disorders and jaundice. Thus, besides the chewing of Garcinia seeds for entertainment during celebrations, other parts of the plants such as the roots and the bark are used in herbal medicines.10 Generally, species of the family Garcinia have been used in the traditional treatments of various ailments such as dysentery, abdominal pains, and diarrhoea.11 The antibacterial biflavonoid of chewing Garcinia kola Kennel have also been isolated and characterised.12 Also, the extracts of the Garcinia seeds are reported by Tchimene et al.13 and Ajayi et al.14 to have anti-inflammatory effects. These reports have therefore confirmed the reasons why the plant was named “wonder plant” due to its medicinal importance.4 Based on the antimicrobial properties of the Garcinia kola seed, Nwaokorie et al.10 reported the effect of the extracts on Fusobacterium nucleatum while the methanolic and aqueous extracts of the kola seeds were evaluated by Penduka et al.4 on Vibrio isolates and reported that both extracts inhibited the activities of the tested organisms. Other proven antimicrobial activities of the seed was earlier reported by various researches10,15-17 Most of the antimicrobial studies about G. kola extracts used different solvent extractions and reported different results. In addition, they used standard bacterial isolates that are sensitive to antibiotics. Therefore in the face of multidrug resistance being experienced clinically, the present study looks to investigate the antimicrobial activity of different extracted fractions of G. kola, on clinical gram negative multidrug resistant bacteria as well as Candida species.

MATERIALS AND METHODS

Plant Material

Garcinia kola seeds were used for this study and had been purchased from vendors in a local market in Lagos Nigeria.

Preparation and fractionation of extract

The seeds weighing 500 g were chopped into small portions, dried and grounded. The powdered seeds were exhaustively extracted three times with methanol for 7 days using 5.0 L of 70 % methanol, at room temperature. The resulting solution was filtered using Whatman Grade1 filter paper, and evaporated to dryness with minimal pressure by the use of rotary evaporator. The residue gave a dark reddish-yellow compound weighing 40.0 g which was then suspended in double distilled water to obtain the aqueous fraction. Also successive extractions were done with hexane (3.0 l), chloroform (3.0 l), ethyl acetate (3.0 l), and butanol (2.0 l). The different extracts were evaporated to dryness to yield hexane fraction (12.0 gm), chloroform fraction (5.0 gm), ethyl acetate fraction (4.0 gm), and butanol fraction (5.0 gm). The remaining aqueous mother liquor was dried to give the water-soluble fraction (13.0 gm). Concentrations of 500 mg/ml was prepared from hexane fraction, chloroform fraction, butanol fraction and aqueous fraction. While 400 mg/ml was prepared from ethyl acetate fraction. Therefore, minimum inhibitory concentrations (MICs) were determined and found to be 25mg/ml for hexane fraction, chloroform fraction, butanol fraction and aqueous fraction. MIC for ethyl acetate was 20mg/ml.

Clinical Isolates

The following clinical Gram negative bacterial and fungal isolates were used for the investigation: Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, Enterobacter species, Serratia marcescens, Candida albicans isolates CF1, CF2, and CF3. They were obtained from the medical microbiology laboratory of the college of medicine at King Faisal University. Isolates had been obtained from clinical samples of blood, sputum diabetic and non-diabetic wounds.

Microbial culture and antibiotic susceptibility testing.

Bacterial isolates were grown on MacConkey agar incubated at 37°C for 24 h. Pure colonies of the isolates were used for the identification and antimicrobial susceptibility testing. Confirmation of the identified isolates was carried out using BioMerieux VITEK 2 compact automated system (BioMerieux, Marcy I’Etoile France), according to the manufacturers guidelines. The antimicrobial susceptibility testing was also carried out using the GN (Gram negative) cards of the BioMerieux VITEK 2 compact automated system (BioMerieux, Marcy I’Etoile France) according to the manufacturer’s guidelines. The GN cards consisted of the following antibiotics: Augmentin, ceftriaxone, cefotaxime, ceftazidime, Cefepime, gentamicin, amikacin, Imipenem, Meropenem, Ciprofloxacin, Levofloxacin, piperacillin-Tazobactam, Colistin, Tigecycline and tetracycline.

Determination of Minimum inhibitory concentrations (MIC)

The MICs of the various fractions of Garcinia Kola ((Heckel) seed extracts were determined by the broth dilution method, according to the method described by Asowata et al.18 All the fractions were prepared to the highest concentration of 500mg ml (stock concentration) in sterile distilled water, which were then serially diluted to give concentrations ranging from 40mg /ml to 10mg ml. 1 ml of the standardized microbial broth cultures were inoculated into the tubes containing the diluted extracts and labelled accordingly. The tubes were incubated at 370C temperature for 24 h for the clinical bacteria isolates and for 48 h for fungi. They were examined for the presence or absence of bacterial or fungal growth. The least concentration of the extract which inhibited the growth of the inoculums was considered as the minimum inhibitory concentration.

RESULTS

The results in Table 1 shows the antimicrobial susceptibility of bacteria isolates used in this study. The least resistance to antimicrobials were Klebsiella pneumonia (MBL 7) and Serratia marcescens (SMC1) with 9. 09 and 18.18 percentage resistance respectively. Both bacterial isolates were from sputum specimens. The antimicrobial resistance pattern for Acinetobacter isolates AC1, AC2, AC3 and AC4 were 85.71%, 57.14%, and 93%, respectively. For the Klebsiella pneumoniae MBL42, MBL 6, and MBL 4, percentage antimicrobial resistance was 92%, 72.72% and 81.82% respectively. These isolates were resistant to at least 3 classes of antibiotic groups and therefore termed multidrug resistant organisms. Out of all the isolates used two were resistant to colistin antibiotics, a drug regarded as the last resort to the treatment of multidrug resistant bacteria. The table also describes different sources of isolates, showing that most of the isolates were from sputum, with only one was from blood sample while A. baumannii, AC1 and AC1 were isolated from diabetic wounds. All the fungal isolates had been from sputum (Table 2). Comparing the susceptibility pattern of diabetic wound isolates with those collected from sputum, in terms of resistance, no main differences were observed. The extent of growth inhibition of the clinical isolates by different fractions of G. kola is described in Table 2. It showed that all the A. baumannii isolates from either diabetic or sputum samples were susceptible to aqueous fraction followed by the butanol fraction, then ethyl acetate fraction and hexane fraction. The chloroform fraction is the least active compared to all the extracted fractions. However, isolates MBL42, MBL6, MBL7, CEC1, MBL4 and SMC1 were however, resistant to all the extracted fractions of G. kola. The table also shows the susceptibility of three different clinical strains of Candida albicans isolates to the various fractions. Of the three, only one (CF1) showed sensitivity to all the fractions, the rest were resistant. Table 3, shows the comparison of antibiotics group with different fractions of G. kola. The results records that aqueous and butanol fractions appeared to have the highest sensitivity on all the A. baumannii multidrug resistant isolates. Their effect on these isolates were similar to the effect produced by tigecycline. One of the isolates (AC3) that was resistant to colistin exhibited sensitivity to both aqueous and butanol fractions of G. kola. The effect of ethyl acetate and hexane fractions were more than that of chloroform fraction. However, all the isolates were resistant to beta lactams, aminoglycosides and fluoroquinolones. Table 4 describes the MICs as obtained from Vitek 2. The MICs for antibiotics against clinical isolates from diabetic wounds, sputum and blood ranged from 0.5- 64µg/ml for both sensitive and resistant isolates. MICs determined for G. kola for this study ranged from 20-25mg/ml. However, these fractions are still in their crude form and therefore not pure compounds. A comparison between percentage resistance to antimicrobials and fractions of G. kola is shown in Figure 1. The least resistant to antibiotic isolates MBL7 and SMC 1 were highly resistant to the G. kola fraction.

Figure 1

A comparison between percentage resistance to antimicrobials and Garcinia kola fractions.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-5-1055_g001.jpg
Table 3

Showing sensitivity of multi-drug resistant clinical isolates of A. baumannii to fractions Garcinia kola

Types of IsolatesSources of IsolatesAntimicrobial groups
CFBFEFHFAQFBLTMAMGFQNCABPTIGCOL
A. baumannii (AC1)Diabetic woundsSSSSSRRRRSS
A. baumannii (AC2)Diabetic woundsSSSSSRSRRSS
A. baumannii (AC3)SputumRSSSSRRRRSR
A. baumannii (AC4)SputumRSRRSRRRRSS

CF: Chloroform Fraction; BF: Butanol Fraction; ethyl acetate Fraction; HF: hexane Fraction; AQF: Aqueous fraction BLTM: Beta-lactam agents; AMG: Aminoglycosides; FQN: Fluoroquinolones; CABP: Carbapenems; TIG: Tigecycline; COL: Colistin

Table 4

Antimicrobial MICs Determined by Vitek 2.

Types of IsolatesSources of IsolatesMICs antibiotics (µg/ml)
AUGCXMCROCTXCAZFEPGMAKIMPMEMCIPLEVOTZPCSTG
A. baumannii (AC1)Diabetic wounds≥ 32≥ 64≥ 64≥64≥ 32≥ 32≥ 16≥ 64≥ 16≥ 16≥ 4≥ 8≥ 16≥ 2≥ 0.5
A. baumannii (AC2)Diabetic wounds≥ 32≥ 64≥ 32≥ 64≥ 8≥ 8≥ 4≥ 16≥ 16≥ 16≥ 0.25≥ 8≥ 16≥ 2≥ 0.5
A. baumannii (AC33)Sputum≥ 32≥ 64≥ 32≥ 64≥ 32≥ 32≥ 16≥ 64≥ 16≥ 16≥ 4≥ 8≥ 4≥ 4≥ 0.5
A. baumannii (AC4)Sputum≥ 32≥ 64≥ 32≥ 64≥ 16≥ 32≥ 16≥ 64≥ 16≥ 16≥ 4≥ 4≥ 8≥ 2≥ 0.5
Klebsiella pneumoniae (MBL 42)Sputum≥ 32≥ 64≥ 64≥64≥ 32≥ 8≥ 16≥ 64≥ 4≥ 8≥ 4≥ 2≥ 16NDND
Klebsiella pneumoniae (MBL 6)Blood≥ 32≥ 64≥ 64≥ 64≥ 32≥ 32≥ 16≥ 16≥ 4≥ 4≥ 4ND≥ 4NDND
Klebsiella pneumoniae (MBL 7)Sputum≥ 8≥ 8≥ 8≥ 32≥ 8≥ 8≥ 4≥ 16≥ 4≥ 4≥ 4ND≥ 4NDND
Escherichia coli (CEC 1)Sputum≥ 32≥ 64≥ 32≥ 32ND≥ 16ND≥ 32≥ 4≥ 8≥ 8≥ 8≥ 4≥ 2≥ 0.5
Klebsiella pneumoniae (MBL 4)Sputum≥ 32≥ 64≥ 64ND≥ 32≥ 32≥ 16≥ 32≥ 16≥ 4≥ 4ND≥ 4≥ 4ND
Serratia marcescens (SMC 1)Sputum≥ 32≥ 64≥ 8≥ 8≥ 8≥ 8≥ 4≥16≥ 4≥ 4≥ 4ND≥ 4NDND

AUG: Augmentin; CXM: cefuroxime; CRO: ceftriaxone; CTX: cefotaxime; CAZ: ceftazidime; FEP: Cefepime; GM: gentamicin; AK: amikacin; IMP: Imipenem; MEM: Meropenem; CIP: ciprofloxacin; LEVO: Levofloxacin; TZP: piperacillin-tazobactam; CS: Colistin; TG: Tigecycline; R/I; Resistant/Intermediate. R = Resistant; S = Sensitive; I = Intermediate.

Table 1

Antimicrobial susceptibility of the gram negative bacterial clinical isolates used in the study

Types of IsolatesSources of IsolatesSusceptibility to antibiotics
AUGCXMCROCTXCAZFEPGMAKIMPMEMCIPLEVOTZPCSTG
A. baumannii (AC1)Diabetic woundsRRRRRRRRRRRRRSS
A. baumannii (AC2)Diabetic woundsRRIRSSSSRRSIRSS
A. baumannii (AC33)SputumRRIRRRRRRRRISRS
A. baumannii (AC4)SputumRRIRIRRRRRRSISS
Klebsiella pneumoniae (MBL 42)SputumRRRRRSRRSIRRRNDND
Klebsiella pneumoniae (MBL 6)BloodRRRRRRRSSSRNDSNDND
Klebsiella pneumoniae (MBL 7)SputumSSSSSSSSSSRNDSNDND
Escherichia coli ( CEC 1)SputumRRIINDINDISIRRSSS
Klebsiella pneumoniae (MBL 4)SputumRRRNDRRRISSRNDSRND
Serratia marcescens (SMC 1)SputumRRSSSSSSSSSNDSNDND

AUzG: Augmentin; CXM: cefuroxime; CRO: ceftriaxone; CTX: cefotaxime; CAZ: ceftazidime; FEP: Cefepime; GM: gentamicin; AK: amikacin; IMP: Imipenem; MEM: Meropenem; CIP: ciprofloxacin; LEVO: Levofloxacin; TZP: piperacillin-tazobactam; CS: Colistin; TG: Tigecycline; R/I; Resistant/Intermediate. R = Resistant; S = Sensitive; I = Intermediate. ND: Not done

Table 2

Showing extent of growth inhibition of clinical microbial isolates by various extracted fractions of Garcinia kola.

Types of IsolatesSources of IsolatesDifferent fractions of Garcinia kola
DMSOCFBFEFHFAQF
A. baumannii (AC1)Diabetic wounds0.6mm14mm14mm11mm11mm16mm
A. baumannii (AC2)Diabetic wounds10mm15mm16mm18mm14mm17mm
A. baumannii (AC33)Sputum10mm10mm12mm16mm16mm18mm
A. baumannii (AC4)Sputum10mm10mm12mm10mm10mm14mm
Klebsiella pneumoniae (MBL 42)Sputum10mm10mm10mm10mm10mm10mm
Klebsiella pneumoniae (MBL 6)Blood10mm10mm10 mm10 mm10 mm10 mm
Klebsiella pneumoniae (MBL 7)Sputum10 mm10 mm10 mm10 mm11 mm15 mm
Escherichia coli ( CEC 1)Sputum10 mm10 mm10 mm10 mm10 mm10 mm
Klebsiella pneumoniae (MBL 4)Sputum10 mm10 mm10 mm10 mm10 mm10 mm
Serratia marcescens (SMC 1)Sputum10 mm10 mm10 mm10 mm10 mm10 mm
Candida albicans (CFI 1)Sputum0 mm12 mm10 mm12 mm13 mm12 mm
Candida albicans (CFI 2)Sputum10 mm10 mm10 mm10 mm10 mm10 mm
Candida albicans (CFI 3)Sputum10 mm10 mm10 mm10 mm10 mm10 mm

DMSO: Dimethyl sulfoxide; CF: Chloroform Fraction; BF: Butanol Fraction; ethyl acetate Fraction; HF: hexane Fraction; AQF: Aqueous fraction

DISCUSSION

The present study showed that G. kola extracts have antimicrobial activity against multi-drug resistance clinical isolates, A. baumannii. The aqueous fraction of G. kola seeds exhibited a better antimicrobial activity as compared to the other fractions. These effects were similar to the results obtained from other studies conducted using antimicrobial sensitive bacteria isolates.19 Our observations also corroborates the findings of Ezeigbo et al.20 who reported growth inhibition with aqueous extracts on gram negative sensitive bacteria. However, a number of studies documented a contrary view, observing that their aqueous extract had little or no antibacterial activity.21-23 Thus pointing to the fact that reports of the antimicrobial effects of G. kola varies between available reports. Interestingly, in the present investigation, a strain of A. baumannii (AC3) clinical isolate that was resistant to colistin, a last line antibiotic, was sensitive to this fraction of G. kola. It was also found to be active against a strain of Candida albicans clinical isolate (CFI 1), an observation that was similar to the work of Penduka and Okoh.22 The butanol fraction of the extract was found to be active against all the A. baumannii isolates and candida albicans (CFI 1). According to Akinpelu et al.16 butanol extract of G. kola, exhibited antibacterial activity against Bacillus anthracis and E. coli sensitive isolates. Thus, with the antifungal effects as seen in this investigation, butanol fraction of G. kola can be said to be exhibiting broad spectrum activity. Regarding the chloroform fraction of the extract, we observed that it was not as active on bacterial growth inhibition as compared to the other fractions. This finding is in line with the study of Akinpelu et al.16 whose investigation with chloroform extract produced no antibacterial activity on sensitive isolates tested. The reason could be that as reported by Morabandza et al.24 chloroform fractions of G. kola contains less flavonoids compared to other fractions. This may account for the reason why it has less antibacterial activity compared to other fractions. The present study also observed that the hexane fraction produced a significant activity against three multidrug resistant clinical isolates of A. baumannii and C. albicans (CFI 1) and can therefore be described as having antimicrobial activities. Similar findings had been reported by other workers who found that hexane fraction of G. kola, had appreciable anti-listeria activity.24 Crude ethyl acetate fraction showed antibacterial activity also like the hexane fraction. Our observation concerning its antibacterial effects was also documented16by researchers, in which they reported significant activity against both gram positive and gram negative bacteria. The said antibacterial activity by them,16 was observed on K. pneumoniae and E. coli at a much lower minimum inhibitory concentration. However, the isolates used in their study were standard laboratory bacterial isolates and not multidrug resistant isolates as those used in the present study. It is worth noting the diversity in bacteria strains such as those of Escherichia coli from those that are pathogenic to the non-pathogenic. In the present investigation, we report that none of the fractions extracts were able to inhibit the growth of multidrug resistant E. coli and K. pneumoniae isolated from clinical source, sputum. The findings could be attributed to the diversity in bacterial stains in as well as their ability to be antibiotic sensitive, MDR or not resistant to antibiotics. The present study also observed that all the fractions appeared to exhibit more activity on diabetic wound isolates than sputum isolates, particularly A. baumannii. The observation that MDR clinical isolate A. baumannii AC3 was sensitive to majority of the fractions of Garcinia kola extract was particularly interesting. This is because, this isolate was resistant to colistin antibiotic, a last line drug usually reserved for treatment of recalcitrant bacteria organisms. The minimum inhibitory concentrations employed in the present study compared to previous studies ranged from 20-25mg/ml. A number of studies reported MIC range of 5-20mg/ml with 20mg/ml MIC showing greater growth inhibition.16,25-26 Therefore, the variation in MICs seen with different studies and also different antibacterial activities reported from extracted fractions could be due to methods and solvent used in the various extractions procedure. Other workers like Penduka and Okoh22 reported MIC of 10mg/ml. Therefore, it is important to harmonise the extraction procedure so as to see a consistent and reproducible results that will serve as a reference. However, for multidrug resistant isolates, a higher MICs will be expected. MICs for antibiotics employed for resistant organisms are usually higher. All the previous studies referred to in this presented study, reported lower antibiotics as positive controls. This is because, their isolates were not multidrug resistant organisms. The range of antibiotics used in this present study was from 4 64µg/ml according to the estimation of the Vitek 2 for the tested multidrug resistant isolates. The consequences of multidrug resistant bacteria infection is far reaching. Finding an alternative therapy that is cheap and non-toxic is crucial but urgent. Because of the availability of herbal plants and safety of their use, coupled with proven efficacy, a lot of interest and attention are focused on them. Garcinia kola products has been shown to be potential medicaments to be used in the treatments of many diseases and scientists have taken interest.20,23 The present study therefore shows that aqueous fraction of Garcinia seeds possesses the potential to be used as antimicrobial agent.

CONCLUSION

Since the effectiveness of current antimicrobial agents are decreasing due to bacterial resistance and treatment failures are experienced by clinicians, the results obtained from this study could provide leads to be further investigated for the development of potential antimicrobial agents of natural origin. G. kola extracts have further shown that they could be useful as potential antibacterial agents.

The researchers would like to thank Dr. Kazeem Yusuf for the provision of the Garcinia kola seeds bought from Nigeria.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

ABBREVIATIONS

MDR

Multidrug resistant

MIC

Minimum inhibitory concentration

AC1

Acinetobacter Clinical isolate 1

AC2

Acinetobacter Clinical isolate 2

AC3

Acinetobacter Clinical isolate 3

AC4

Acinetobacter Clinical isolate 4

MBL 42

Microbiology lab 42

MBL 4

Microbiology lab 42

MBL 6

Microbiology lab 42

MBL 7

Microbiology lab 42

CEC 1

Clinical Escherichia coli 1

SMC 1

Serratia marcescens Clinical isolate 1

CF1

Clinical fungi isolate 1

CF2

Clinical fungi isolate 2

CF3

Clinical fungi isolate 3.

REFERENCES

1. 

Emeka PM, Badger-Emeka LI, Fateru F , authors. In vitro antimicrobial activities of Acalypha ornate leaf extracts on bacterial and fungal clinical isolates. Journal of Herbal Medicine. 2012;2(4):136–42

2. 

Sofowora A , author. Medicinal plants and traditional medicine in Africa. 3. Ibadan: Spectrum Books Limited; 2008. p. 179–93

3. 

Parekh J, Jadeja D, Chanda S , authors. Efficacy of aqueous and methanol extract of some medicinal plants for potential antibacterial activity. Turk J Biol Sci. 2005;29(4):203–10

4. 

Penduka D, Okoh OO, Okoh AI , authors. In-vitroAntagonistic Characteristics of Crude Aqueous and Methanolic Extracts ofGarcinia kola(Heckel) Seeds against Some Vibrio Bacteria. Molecules. 2011;16(4):2754–65. http://doi:10.3390/molecules16042754.

5. 

Adefule AO, Adefule AK, Oosa BO, Onyenefa PC , authors. Antifungal activity of Garcinia kola nut extract as an ocular bacterial isolates in Lagos. Nig Q J Hosp Med. 2004;14:112–4

6. 

Seruji NMU, Khong HY, Kutoi CJ , authors. Antioxidant, anti-inflammatory and Cytotoxic activities of Garcinia nervosa (Clusiaceae). Hindawi publishing cooperation. J Chem. 2013;11:1–5. http://dx.doi.org/10.1155/2013/913406.

7. 

Adebisi AA , author. A case study of Garcinia kola nut production-to consumption system in J4 Area of Omo forest reserve, Southwest Nigeria. Sunderland T, Ndoye O , editors. Forest products, livelihoods and conservation: case studies on non-timber forest systems Bogor Barat: Center for International Forstry Research; 2004. p. 115–32

8. 

Han YW, Ikegami A, Rajanna C, Kawsar H, Zhou Y, Li M , authors. et al. Identification and characterization of novel adhesin unique to oral Fusobacteria. J Bacteriol. 2005;187(15):5330–40

9. 

Iwu MM , author. Handbook of African Medicinal Plants. CRC Press; Boca Raton, FL, USA: 1993. p. 183–4

10. 

Nwaokorie F, Coker A, Ogunsola F, Gaetti-Jardim JE, Gabriel O, Ayanbadejo P , authors. et al. Antimicrobial activities of Garcinia kola on oral Fusobacterium nucleatum and biofilm. African Journal of Microbiology Research. 2010;4(7):509–14. http://www.academicjournals.org/ajmr

11. 

Jayaprakasha GK, Negi PS, Jena BS , authors. Antioxidative and antimutagenic activities of the extracts from the rinds of Garcinia pedunculata. Innovative Food Science and Emerging Technologies. 2006;7(3):246–50

12. 

Xu HX, Mughal S, Taiwo O, Lee SF , authors. Isolation and characterization of an antibacterial biflavonoid from an African chewing stick Garcinia kola Heckel (Clusiaceae). Ethnopharmacol. 2013;147(2):497–502. doi: 10.1016/j.jep.2013.03.047.

13. 

Tchimene KM, Anaga AO, Ugwoke CEC, Ezugwu CO, Okunji C, Iwu MM , authors. Bio-flavonoids and Garcinoic Acid from Garcinia kola seeds with Promising Anti-Inflammatory Potentials. Pharmacognosy Journal. 2016;8(1):56–8

14. 

Ajayi SA, Ofusori DA, Ojo GB, Ayoka OA, Abayomi TA, Tijani AA , authors. The microstructural effects of aqueous extract of Garcinia kola (Linn) on the hippocampus and cerebellum of malnourished mice. Asian Pac J Trop Biomed. 2011;1(4):261–5. http://doi:10.1016/S2221-1691(11)60039-7.

15. 

Sibanda T, Okoh AI , authors. In-vitro antibacterial regimes of crude aqueous and acetone extracts of Garcinia kola seeds. J Biol Sci. 2008;8(1):149–54

16. 

Akinpelu DA, Adegboye MF, Adeloye OA, Okoh AI , authors. Biocidal activity of partially purified fractions from methanolic extract of Garcinia kola (Heckel) seeds on bacterial isolates. Biol Res. 2008;41(3):277–87

17. 

Ezeifeka GO, Orji MU, Mbata TI, Patrick AO , authors. Antimicrobial activities of Cajanus cajan, Garcinia kola and Xylopia aethiopica on pathogenic microorganisms. Biotechnology. 2004;3(1):41–3

18. 

Asowata I, Erhabor JO, Idu M, Odaro T, Obayagbona NO , authors. Preliminary antimicrobial and phytochemical study of the aqueous, alcoholic and chloroform extracts of the leaves of Napoleonaea vogelli Hook and Planch. (Lecythidiaceae). J Microbiol Biotechnol Food Sci. 2013;2(4):2279–92

19. 

Njume C, Jide AA, Ndip RN , authors. Aqueous and Organic Solvent-Extracts of Selected South African Medicinal Plants Possess Antimicrobial Activity against Drug-Resistant Strains of Helicobacter pylori: Inhibitory and Bactericidal Potential. International Journal of Molecular Sciences. 2011;12(9):5652–65. doi:10.3390/ijms12095652.

20. 

Ezeigbo OR, Ejike EN, Nwachukwu I, Ejike BU , authors. Comparative Antibacterial Activity of Methanolic, Ethanolic and Aqueous Extract of Garcinia kola (Bitter kola) and Cola nitida (Kola nut). International Journal of Plant Research. 2016;6(3):53–6. doi: 10.5923/j.plant.20160603.01.

21. 

Sibanda T, Olaniran AO, Okoh AI , authors. In-vitro antibacterial activities of crude extracts of Garcinia kolaseeds against wound sepsis associated Staphylococcus strains. J Med Plants Res. 2010;4:710–6

22. 

Penduka D, Okoh AI , authors. In vitro Anti-Listerial Activities of Crude n-Hexane and Aqueous Extracts of Garcinia kola (heckel) Seeds. International Journal of Molecular Sciences. 2011;12(10):6952–65. doi:10.3390/ijms12106952.

23. 

Seanego CT, Ndip RN , authors. Identification and Antibacterial Evaluation of Bioactive Compounds from Garcinia kola (Heckel) Seeds. Molecules. 2012;17(6):6569–84

24. 

Morabandza CJ, Ongoka RP, Matini L, Epa C, Nkounkou LC, Abena AA , authors. Chemical Composition of the Mesocarp of Garcinia kola Heckel (Clusiaceae) Fruit. Research Journal of Recent Sciences. 2013;2(1):53–8

25. 

Adeleke OE, Coker ME, Oke OB , authors. Detection of a Gentamicin-Resistant Burn Wound Strain of Pseudomonas Aeruginosa but Sensitive to Honey and Garcinia Kola (Heckel) Seed Extract. Annals of Burns and Fire Disasters. 2010;23(2):102–5

26. 

Akinnibosun FI, Itedjere E , authors. Evaluation of the antibacterial properties and synergistic effect of Garcinia kola Heckel (Family: Guttiferae) seed extract and honey on some bacteria. African Journal of Microbiology Research. 2013;7(3):174–80. DOI: 10.5897/AJMR12.1331.

PICTORIAL ABSTRACT

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-5-1055_g002.jpg

SUMMARY

  • Different fractions extract from Garcinia kola, inhibited the growth of multidrug resistant A. baumanni and C. albicans.